GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taro Pharmaceutical Industries Ltd (FRA:TAL) » Definitions » Current Deferred Taxes Liabilities

Taro Pharmaceutical Industries (FRA:TAL) Current Deferred Taxes Liabilities : €0.0 Mil (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Taro Pharmaceutical Industries Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Taro Pharmaceutical Industries's current deferred tax liabilities for the quarter that ended in Dec. 2023 was €0.0 Mil.

Taro Pharmaceutical Industries Current Deferred Taxes Liabilities Historical Data

The historical data trend for Taro Pharmaceutical Industries's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taro Pharmaceutical Industries Current Deferred Taxes Liabilities Chart

Taro Pharmaceutical Industries Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Current Deferred Taxes Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Taro Pharmaceutical Industries Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Current Deferred Taxes Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Taro Pharmaceutical Industries Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Taro Pharmaceutical Industries's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Taro Pharmaceutical Industries (FRA:TAL) Business Description

Traded in Other Exchanges
Address
14 Hakitor Street, P.O. Box 10347, Haifa Bay, Haifa, ISR, 2624761
Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.

Taro Pharmaceutical Industries (FRA:TAL) Headlines

From GuruFocus

TAL Education Group: Company Investigated by the Portnoy Law Firm

By sperokesalga sperokesalga 05-29-2023